Funded Tech Companies

HilleVax

Based in Boston, HilleVax has funding from BVF Partners, Deerfield Capital and Lightspeed Venture Partners.

Company Overview

Contact Information

Company Background Information

Overview

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/9/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Hershberg

        

Chief Financial Officer

David Socks

        

Chief Medical Officer

Astrid Borkowski

        

Chief Operating Officer

Aditya Kohli

        

VP - Administration

Paul Bavier

        

Company Investors

• BVF Partners
• Deerfield Capital
• Lightspeed Venture Partners
• Qiming Ventures
• Greenspring Global Partners
• Frazier Healthcare Partners
• Abingworth
• Samsara BioCapital
• RA Capital
• Sahsen Ventures
• Catalys Pacific
• Perceptive Advisors
• Franklin Templeton
• Richard King Mellon Foundation

Browse more funded tech companies:

Hillcrest Laboratories | Hillhurst Biopharmaceuticals

Share this article

About Our Venture Capital Transactions Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary